![]() |
Volumn 13, Issue 3, 2008, Pages 320-329
|
The clinical approach towards chondrosarcoma (Oncologist (2008) 13, (320-329) DOI: 10.1634/theoncologist.2007-0237);The clinical approach towards chondrosarcoma
|
Author keywords
Chemotherapy; Chondrosarcoma; Classification; Mesenchymal chondrosarcoma; Radiotherapy; Review
|
Indexed keywords
ANTINEOPLASTIC AGENT;
APOMAB;
CISPLATIN;
DASATINIB;
DOCETAXEL;
DOXORUBICIN;
GEMCITABINE;
METHOTREXATE;
PERIFOSINE;
BONE GRAFT;
BONE MINERALIZATION;
CANCER ADJUVANT THERAPY;
CANCER GRADING;
CANCER LOCALIZATION;
CANCER RADIOTHERAPY;
CANCER SURGERY;
CELL DIFFERENTIATION;
CHONDROSARCOMA;
CLINICAL TRIAL;
COMPUTER ASSISTED TOMOGRAPHY;
CURETTAGE;
DIAGNOSTIC PROCEDURE;
DISEASE CLASSIFICATION;
DRUG MEGADOSE;
ENCHONDROMA;
HISTOPATHOLOGY;
HUMAN;
MESENCHYME CELL;
MONOTHERAPY;
NUCLEAR MAGNETIC RESONANCE IMAGING;
OSTEOCHONDROMA;
PELVIS;
PRIORITY JOURNAL;
RADIODIAGNOSIS;
REVIEW;
SOFT TISSUE;
|
EID: 43549101708
PISSN: 10837159
EISSN: 1549490X
Source Type: Journal
DOI: 10.1634/theoncologist.2007-0237erratum Document Type: Erratum |
Times cited : (563)
|
References (91)
|